Recent studies have further showed that a primary influenza A virus infection can elevate the expression of ACE2 in humans, suggesting that the co‐infection of COVID‐19 and influenza A may lead to an aggravated clinical manifestation.21 The gene discussed is ACE2; the disease is COVID-19.